Elisabeth Bandak1, Anders F Overgaard1, Lars Erik Kristensen1, Karen Ellegaard1, Jørgen Guldberg-Møller1, Cecilie Bartholdy1, David J Hunter2,3, Roy D Altman4, Robin Christensen1,5, Henning Bliddal1, Marius Henriksen6. 1. The Parker Institute, Copenhagen University Hospital Bispebjerg-Frederiksberg, Copenhagen, Denmark. 2. Institute of Bone and Joint Research, Kolling Institute of Medical Research, The University of Sydney, Sydney, Australia. 3. Department of Rheumatology, Royal North Shore Hospital, Odense, Australia. 4. Ronald Reagan UCLA Medical Center, Los Angeles, CA, USA. 5. Research Unit of Rheumatology, Department of Clinical Research, University of Southern Denmark, Odense University Hospital, Odense, Denmark. 6. The Parker Institute, Copenhagen University Hospital Bispebjerg-Frederiksberg, Copenhagen, Denmark. marius.henriksen@regionh.dk.
Abstract
BACKGROUND:Knee osteoarthritis (OA) is a highly prevalent musculoskeletal condition causing pain, physical disability, and reduced quality of life. Exercise and patient education are non-pharmacological interventions for knee OA unanimously recommended as first-line treatments based on extensive research evidence. However, none of the numerous randomised controlled trials of exercise and education for knee OA has used adequate sham/placebo comparison groups because the 'active' ingredients are unknown. Designing and executing an adequate and 'blindable placebo' version of an exercise and education intervention is impossible. Therefore, using an open-label study design, this trial compares the efficacy of a widely used 'state-of-art' exercise and education intervention (Good Life with osteoarthritis in Denmark; GLAD) with presumably inert intra-articular saline injections on improvement in knee pain in patients with knee OA. METHODS: In this open-label randomised trial, we will include 200 patients with radiographically verified OA of the knee and randomly allocate them to one of two interventions: (i) 8 weeks ofexercise and education (GLAD) or (ii) Intra-articular injections of 5 ml isotonic saline every second week for a total of 4 injections. Outcomes are taken at baseline, after 8 weeks of treatment (week 9; primary endpoint) and after an additional 4 weeks of follow-up (week 12). The primary outcome is change from baseline in the Knee Injury and Osteoarthritis Outcome Score questionnaire (KOOS) pain subscale score. Secondary outcomes include the Physical function in Activities of Daily Living, Symptoms, and Knee-related Quality of Life subscales of the KOOS, the patients' global assessment of disease impact, physical performance tests, and presence of knee joint swelling. DISCUSSION: This current trial compares a presumably active treatment (GLAD) with a presumably inert treatment (IA saline injections). Both study interventions have well-established and anticipated similar effects on knee OA symptoms, but the underlying mechanisms are unknown. The interpretation of the results of this trial will likely be difficult and controversial but will contribute to a better understanding of the bias introduced in the effect estimation of classically unblindable exercise and education interventions for knee OA. TRIAL REGISTRATION: www.ClinicalTrials.gov NCT03843931 . Prospectively registered on 18 February 2019.
RCT Entities:
BACKGROUND: Knee osteoarthritis (OA) is a highly prevalent musculoskeletal condition causing pain, physical disability, and reduced quality of life. Exercise and patient education are non-pharmacological interventions for knee OA unanimously recommended as first-line treatments based on extensive research evidence. However, none of the numerous randomised controlled trials of exercise and education for knee OA has used adequate sham/placebo comparison groups because the 'active' ingredients are unknown. Designing and executing an adequate and 'blindable placebo' version of an exercise and education intervention is impossible. Therefore, using an open-label study design, this trial compares the efficacy of a widely used 'state-of-art' exercise and education intervention (Good Life with osteoarthritis in Denmark; GLAD) with presumably inert intra-articular saline injections on improvement in knee pain in patients with knee OA. METHODS: In this open-label randomised trial, we will include 200 patients with radiographically verified OA of the knee and randomly allocate them to one of two interventions: (i) 8 weeks of exercise and education (GLAD) or (ii) Intra-articular injections of 5 ml isotonic saline every second week for a total of 4 injections. Outcomes are taken at baseline, after 8 weeks of treatment (week 9; primary endpoint) and after an additional 4 weeks of follow-up (week 12). The primary outcome is change from baseline in the Knee Injury and Osteoarthritis Outcome Score questionnaire (KOOS) pain subscale score. Secondary outcomes include the Physical function in Activities of Daily Living, Symptoms, and Knee-related Quality of Life subscales of the KOOS, the patients' global assessment of disease impact, physical performance tests, and presence of knee joint swelling. DISCUSSION: This current trial compares a presumably active treatment (GLAD) with a presumably inert treatment (IA saline injections). Both study interventions have well-established and anticipated similar effects on knee OA symptoms, but the underlying mechanisms are unknown. The interpretation of the results of this trial will likely be difficult and controversial but will contribute to a better understanding of the bias introduced in the effect estimation of classically unblindable exercise and education interventions for knee OA. TRIAL REGISTRATION: www.ClinicalTrials.gov NCT03843931 . Prospectively registered on 18 February 2019.
Authors: C Bartholdy; S M Nielsen; S Warming; D J Hunter; R Christensen; M Henriksen Journal: Osteoarthritis Cartilage Date: 2018-09-22 Impact factor: 6.576
Authors: Marlene Fransen; Sara McConnell; Alison R Harmer; Martin Van der Esch; Milena Simic; Kim L Bennell Journal: Cochrane Database Syst Rev Date: 2015-01-09
Authors: An-Wen Chan; Jennifer M Tetzlaff; Peter C Gøtzsche; Douglas G Altman; Howard Mann; Jesse A Berlin; Kay Dickersin; Asbjørn Hróbjartsson; Kenneth F Schulz; Wendy R Parulekar; Karmela Krleza-Jeric; Andreas Laupacis; David Moher Journal: BMJ Date: 2013-01-08
Authors: Kim L Bennell; Thorlene Egerton; Joel Martin; J Haxby Abbott; Ben Metcalf; Fiona McManus; Kevin Sims; Yong-Hao Pua; Tim V Wrigley; Andrew Forbes; Catherine Smith; Anthony Harris; Rachelle Buchbinder Journal: JAMA Date: 2014-05-21 Impact factor: 56.272
Authors: Marius Henriksen; Robin Christensen; Louise Klokker; Cecilie Bartholdy; Elisabeth Bandak; Karen Ellegaard; Mikael P Boesen; Robert G Coumine Riis; Else M Bartels; Henning Bliddal Journal: JAMA Intern Med Date: 2015-06 Impact factor: 21.873
Authors: R R Bannuru; M C Osani; E E Vaysbrot; N K Arden; K Bennell; S M A Bierma-Zeinstra; V B Kraus; L S Lohmander; J H Abbott; M Bhandari; F J Blanco; R Espinosa; I K Haugen; J Lin; L A Mandl; E Moilanen; N Nakamura; L Snyder-Mackler; T Trojian; M Underwood; T E McAlindon Journal: Osteoarthritis Cartilage Date: 2019-07-03 Impact factor: 6.576
Authors: Toby O Smith; Gillian A Hawker; David J Hunter; Lyn M March; Maarten Boers; Beverley J Shea; Robin Christensen; Francis Guillemin; Caroline B Terwee; Paula R Williamson; Susanna Dodd; Ewa M Roos; Richard F Loeser; Thomas J Schnitzer; Margreet Kloppenburg; Tuhina Neogi; Christoph H Ladel; Gurdyal Kalsi; Ulrike Kaiser; Thomas W Buttel; Anne E Ashford; Ali Mobasheri; Nigel K Arden; Alan Tennant; Marc C Hochberg; Maarten de Wit; Peter Tugwell; Philip G Conaghan Journal: J Rheumatol Date: 2019-01-15 Impact factor: 4.666
Authors: Allan Villadsen; Søren Overgaard; Anders Holsgaard-Larsen; Robin Christensen; Ewa M Roos Journal: J Rheumatol Date: 2014-06-15 Impact factor: 4.666
Authors: Tammy C Hoffmann; Paul P Glasziou; Isabelle Boutron; Ruairidh Milne; Rafael Perera; David Moher; Douglas G Altman; Virginia Barbour; Helen Macdonald; Marie Johnston; Sarah E Lamb; Mary Dixon-Woods; Peter McCulloch; Jeremy C Wyatt; An-Wen Chan; Susan Michie Journal: BMJ Date: 2014-03-07
Authors: Francisco Corbi; Sergi Matas; Jesús Álvarez-Herms; Sebastian Sitko; Ernest Baiget; Joaquim Reverter-Masia; Isaac López-Laval Journal: Healthcare (Basel) Date: 2022-05-30